US Stock Movers
Live U.S. stock market movers ranked by gains, losses & volume with AI-powered reasons for every move.
| Name | Price | Today | Market Cap | Event Catalyst |
|---|---|---|---|---|
| $1.450 | -87.71% | 181.44M | No recent news explains PSIG's drastic -88.73% price decline. | |
| $1.200 | -40.00% | 7.39M | CELZ's stock dropped 29.50% despite no recent news or sector strength. | |
| $1.020 | -38.92% | 27.45M | Positive news and sector strength significantly boosted investor sentiment around LICN's stock price. | |
| $3.700 | -37.82% | 0.00 | USDE's stock price fell -36.97% without any specific news or momentum driving the decline. | |
| $1.500 | -36.44% | 22.14M | -- | |
| $0.740 | -35.09% | 10.85M | BTC Digital Ltd. secured $7 million financing, but market skepticism overshadowed this positive news. | |
| $3.410 | -34.42% | 48.77M | Recent negative earnings report caused investor panic, leading to a -15.38% drop in ANGH's stock price. | |
| $0.950 | -33.57% | 896.41K | Kustom's divestiture of video solutions for $5.5 million led to profit-taking after a significant price surge. | |
| $2.600 | -31.40% | 31.47M | Securities claims investigation announced, impacting investor confidence and driving stock down after previous gains. | |
| $0.358 | -31.35% | 174.00M | -- | |
| $0.454 | -31.17% | 47.98M | Recent negative news triggered panic selling, leading to a significant stock price drop. | |
| $1.050 | -27.08% | 27.43M | -- | |
| $1.080 | -27.03% | 13.91M | Investor skepticism persists despite recent franchise openings, contributing to RMCF's stock decline. | |
| $12.770 | -26.82% | 7.72B | -- | |
| $0.806 | -26.73% | 6.77M | -- | |
| $2.010 | -26.64% | 4.30M | -- | |
| $7.000 | -26.62% | 39.95M | -- | |
| $1.130 | -26.14% | 24.48M | ONEG's stock dropped -18.30% despite sector strength and no specific news explaining the decline. | |
| $2.900 | -24.48% | 30.93M | -- | |
| $90.650 | -23.66% | 46.53B | ON Semiconductor's shares fell 17% due to skepticism over its $7 billion acquisition of Synaptics. | |
| $0.341 | -23.04% | 13.74M | Recent negative news triggered investor panic, leading to a significant drop in JSPR's stock price. | |
| $0.479 | -22.74% | 21.62M | -- | |
| $0.740 | -21.37% | 69.33M | South Korea's IPO activity plummeted, significantly impacting market sentiment and LGCL's stock price. | |
| $0.362 | -21.30% | 28.89M | -- | |
| $0.825 | -21.05% | 73.81M | -- | |
| $0.418 | -19.29% | 3.72M | CNEY surged +33.82% despite broader market declines and sector losses. | |
| $8.670 | -19.12% | 775.86M | Omeros received a negative EMA opinion on narsoplimab, causing a ~25% pre-market drop. | |
| $0.910 | -18.75% | 59.03M | -- | |
| $2.100 | -18.60% | 1.71M | -- | |
| $252.020 | -18.49% | 87.94B | Profit-taking after a 1,410% surge led to the recent decline in Bloom Energy's stock price. | |
| $0.850 | -18.27% | 84.54M | -- | |
| $1.840 | -18.22% | 14.72M | -- | |
| $1.240 | -17.33% | 66.82M | -- | |
| $16.720 | -17.23% | 199.72M | WYY's stock surged 91% after a DHS contract announcement, leading to an eventual decline of -8.42%. | |
| $0.264 | -16.71% | 37.74M | -- | |
| $2.160 | -16.60% | 164.94M | -- | |
| $3.150 | -16.45% | 28.61M | VCIG's stock fell despite strengthening equity structure with Esousa Holdings, indicating mixed investor sentiment. | |
| $0.336 | -16.02% | 7.84M | -- | |
| $3.870 | -15.32% | 9.24M | ESHallGo's $1.479 million stock offering raised concerns, contributing to the significant price drop. | |
| $0.255 | -15.23% | 15.22M | -- | |
| $5.960 | -15.10% | 26.10M | IceCure Medical regained Nasdaq compliance but faced significant volatility leading to a -24.52% drop. | |
| $2.750 | -14.86% | 8.21M | -- | |
| $0.132 | -14.84% | 9.29M | -- | |
| $0.0119 | -14.60% | 1.31M | GDC announced a 1-for-250 reverse stock split, impacting market perception significantly. | |
| $7.130 | -14.30% | 15.13M | -- | |
| $1.680 | -14.29% | 46.89M | -- | |
| $0.34 | -13.92% | 62.13M | -- | |
| $2.070 | -13.75% | 17.81M | -- | |
| $0.888 | -13.69% | 21.73M | -- | |
| $3.750 | -13.59% | 17.33M | Jinxin Technology's product launch and awards overshadowed NAMI's performance, impacting market sentiment. |
